ARCAS: Analysis of the Route to Commercialisation of MVA based influenza vaccines

Project Information

ARCAS

Grant agreement ID: 324634

Project closed

Start date 1 December 2012

End date 30 November 2013

Funded under

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 164 400,00

EU contribution € 149 840,00

Coordinated by

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands